当前位置:首页 - 行情中心 - 亿帆医药(002019) - 财务分析 - 现金流量表

亿帆医药

(002019)

  

流通市值:129.00亿  总市值:186.47亿
流通股本:8.41亿   总股本:12.16亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,631,060,431.191,322,551,834.764,883,376,838.973,840,344,662.08
  收到的税费返还33,638,066.6920,511,692.6786,321,647.8379,166,446.31
  收到其他与经营活动有关的现金109,937,545.1968,552,508.69357,428,098.84194,208,996.45
  经营活动现金流入小计2,774,636,043.071,411,616,036.125,327,126,585.644,113,720,104.84
  购买商品、接受劳务支付的现金1,509,961,598.07706,995,791.042,042,147,533.691,815,670,397.88
  支付给职工以及为职工支付的现金417,759,027.89238,119,151.85795,480,074.94614,398,547.97
  支付的各项税费228,444,365.29159,921,795.37408,011,619.98300,267,912.12
  支付其他与经营活动有关的现金332,373,980.59124,243,880.571,440,757,164.381,029,973,622.8
  经营活动现金流出小计2,488,538,971.841,229,280,618.834,686,396,392.993,760,310,480.77
  经营活动产生的现金流量净额286,097,071.23182,335,417.29640,730,192.65353,409,624.07
二、投资活动产生的现金流量:
  收回投资收到的现金80,867,574-791,461,040.25475,879,324
  取得投资收益收到的现金1,192,516.18-2,668,983.311,035,831.99
  处置固定资产、无形资产和其他长期资产收回的现金净额7,227,5303,820,416321,264192,313.6
  处置子公司及其他营业单位收到的现金净额--5,287,258.815,287,258.81
  投资活动现金流入小计89,287,620.183,820,416799,738,546.37482,394,728.4
  购建固定资产、无形资产和其他长期资产支付的现金248,329,030.27111,178,114.14628,156,384.41385,213,076.39
  投资支付的现金--716,461,040.25465,879,324
  投资活动现金流出小计248,329,030.27111,178,114.141,344,617,424.66851,092,400.39
  投资活动产生的现金流量净额-159,041,410.09-107,357,698.14-544,878,878.29-368,697,671.99
三、筹资活动产生的现金流量:
  吸收投资收到的现金--1,000,0001,000,000
  其中:子公司吸收少数股东投资收到的现金--1,000,0001,000,000
  取得借款收到的现金745,241,619.89517,691,345.272,001,328,182.481,696,424,044.34
  收到其他与筹资活动有关的现金443,942.15295,840.534,292,003.9234,011,802.57
  筹资活动现金流入小计745,685,562.04517,987,185.772,036,620,186.41,731,435,846.91
  偿还债务支付的现金737,867,333.88585,688,486.041,692,852,819.41,173,759,041.66
  分配股利、利润或偿付利息支付的现金148,116,433.3613,758,260.06207,734,220.62192,954,021.33
  其中:子公司支付给少数股东的股利、利润--12,921,125.6412,919,696.37
  支付其他与筹资活动有关的现金7,115,037.334,914,870.3523,301,426.0520,080,136.52
  筹资活动现金流出小计893,098,804.57604,361,616.451,923,888,466.071,386,793,199.51
  筹资活动产生的现金流量净额-147,413,242.53-86,374,430.68112,731,720.33344,642,647.4
四、汇率变动对现金及现金等价物的影响15,504,362.212,144,060.32-3,691,057.98-2,338,325.28
五、现金及现金等价物净增加额-4,853,219.18-9,252,651.21204,891,976.71327,016,274.2
  加:期初现金及现金等价物余额777,637,857.9777,637,857.9572,745,881.19572,745,881.19
  期末现金及现金等价物余额772,784,638.72768,385,206.69777,637,857.9899,762,155.39
补充资料:
  净利润284,158,135.82-323,621,712.62-
  资产减值准备11,333,286.25-164,891,357.65-
  固定资产和投资性房地产折旧67,188,319.1-122,293,825.84-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧67,188,319.1-122,293,825.84-
  无形资产摊销107,133,941.9-198,531,474.31-
  长期待摊费用摊销8,372,517.71-9,931,445.18-
  处置固定资产、无形资产和其他长期资产的损失-3,858,234.66--30,145,653.64-
  固定资产报废损失469,013.54-676,450.07-
  公允价值变动损失459,827.92---
  财务费用25,822,154.1-69,100,599.7-
  投资损失14,370,446.64-14,164,575.31-
  递延所得税12,599,612.68-4,597,712.37-
  其中:递延所得税资产减少14,790,636.3-12,604,887.77-
    递延所得税负债增加-2,191,023.62--8,007,175.4-
  存货的减少-139,529,178.88--147,751,762.24-
  经营性应收项目的减少-229,417,724.67--363,718,239-
  经营性应付项目的增加93,889,792.62-239,989,502.62-
  其他26,592,124.48-19,705,816.39-
  现金的期末余额772,784,638.72-777,637,857.9-
  减:现金的期初余额777,637,857.9-572,745,881.19-
  现金及现金等价物的净增加额-4,853,219.18-204,891,976.71-
公告日期2025-08-152025-04-302025-04-282024-10-31
审计意见(境内)标准无保留意见
TOP↑